Results 171 to 180 of about 56,557 (303)
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber +7 more
wiley +1 more source
The evolution of azole resistance through a reduced spore dormancy pathway associated with loss of SUMOylation function in <i>Fusarium graminearum</i>. [PDF]
Wog K +3 more
europepmc +1 more source
Aims Vincristine‐induced peripheral neuropathy (VIPN) is a common side effect in children and adolescents treated with vincristine. Assessing VIPN, especially in young children, is challenging due to a lack of sensitive tools. This limits our understanding of the nature and risk factors of VIPN. This study aimed to investigate neurofilament light chain
Peter Erik Lotko Pontoppidan +8 more
wiley +1 more source
Impact of Wheat Crop Management on Co-occurrence of Group B Trichothecenes: Crop Practices Influencing DON and Derivatives in Wheat. [PDF]
João Paulo A +6 more
europepmc +1 more source
Aims Electronic triggers (e‐triggers) are used as screening signals to detect potential adverse drug events (ADEs) and offer an effective system level approach for medication safety surveillance. Their clinical utility is typically evaluated through time‐consuming manual chart review by experts, limiting implementation.
Anne Paulien Langermans +40 more
wiley +1 more source
Three Bacterial Endophytes Enhanced Plant Growth and Yield and Reduced the Severity of <i>Phytophthora capsici</i> in Bell Pepper and Tomato Plants in the Field. [PDF]
Ambachew D +6 more
europepmc +1 more source
Abstract Aim Although regulatory responses to safety signals have been studied, pregnancy‐specific data and their dissemination to medical professionals remain unclear. This study examined the characteristics and temporal trends of teratological safety signals prompting the European Medicines Agency to implement risk minimization measures.
Yrea R. J. van Rijt‐Weetink +9 more
wiley +1 more source
A combined genetic and chemical approach for identifying novel antifungal compounds against <i>Fusarium graminearum</i>. [PDF]
Shin S +11 more
europepmc +1 more source
Aims CYP2C19 is one of the most important pharmacogenes, and its activity is highly variable due to factors such as genetics or drug–drug interactions. Due to the lack of an appropriate endogenous CYP2C19 biomarker, surrogate methods to assess its activity are warranted.
Julian Peter Müller +9 more
wiley +1 more source
Isolation, Identification, and Management Strategies for the Root Rot Pathogen of <i>Cardamine violifolia</i>. [PDF]
Gao S +13 more
europepmc +1 more source

